Scholarlink

<p>Cross-sectoral care in oncology is considered key to improving efficiency, quality of care, and patient outcomes. However, health economic analyses paint a&#xa0;sobering picture. Studies of certified oncology centers show that coordinated care can reduce overall costs per patient and improve survival, yet the specific contribution of cross-sectoral integration remains unclear. Despite positive effects on patient satisfaction, the existing economic and organizational evidence is insufficient to justify implementation in routine care. Reductions in duplicate diagnostics or rehospitalizations are often assumed but only sparsely quantified empirically. Major barriers include limited digital interoperability and inadequate reimbursement mechanisms, while investment requirements—particularly for IT infrastructure and interface management—are substantial. Overall, without robust outcome measurement, appropriate incentive structures, and long-term financing, potential benefits cannot be realized. Development of evidence-based governance mechanisms is therefore essential to ensure that cancer care is both fit for the future and economically sustainable.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Gesundheitsökonomische Auswirkungen und Effekte sektorenübergreifender Versorgungssteuerung

  • 期刊论文

  • 发表日期：

    2026年3月5日

查看全文
  • Florian Kron,
  • Phil-Luis Reich,
  • Robert Dengler

摘要

Cross-sectoral care in oncology is considered key to improving efficiency, quality of care, and patient outcomes. However, health economic analyses paint a sobering picture. Studies of certified oncology centers show that coordinated care can reduce overall costs per patient and improve survival, yet the specific contribution of cross-sectoral integration remains unclear. Despite positive effects on patient satisfaction, the existing economic and organizational evidence is insufficient to justify implementation in routine care. Reductions in duplicate diagnostics or rehospitalizations are often assumed but only sparsely quantified empirically. Major barriers include limited digital interoperability and inadequate reimbursement mechanisms, while investment requirements—particularly for IT infrastructure and interface management—are substantial. Overall, without robust outcome measurement, appropriate incentive structures, and long-term financing, potential benefits cannot be realized. Development of evidence-based governance mechanisms is therefore essential to ensure that cancer care is both fit for the future and economically sustainable.